Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Disease Area

Disease Area Pain & critical care

Putting Your Back into It

| Jonathan James

Progress in tissue engineering may offer hope to patients suffering from debilitating intervertebral disc degeneration.

Disease Area Neurological

A Neural Precedent

| Jonathan James

Interneuron activity suggests that there’s more to the story of seizure onset

Disease Area Neuroscience

Brain Network Manipulation

| Jonathan James

Cutting-edge imaging, predictive modeling and gene therapy combine for a new direction in neurodegenerative disease research

Disease Area Infectious diseases

Andes Antibody Advancement

| Jonathan James

A antibody discovery platform emerges to tackle the growing problem of Andes Hantavirus cardiopulmonary syndrome (AHCPS)

Disease Area Cancer

More than METs the Eye

| Jonathan James

The role of different types of MET mutation in lung cancer could demand a rethink of treatments.

Disease Area Immunology

Just One Shot

| Stephanie Sutton

A vaccine using mRNA demonstrates potential for broad influenza protection.

Disease Area Analytical science

Real-Time Tumor Analysis

| William Aryitey

MALDI and a SpiderMass device could save valuable surgery time

Disease Area Diagnostics & prognostics

Markers for Prognostic Progress

| Ana Robles

Better lung cancer treatment through biomarkers

Disease Area Drug discovery

Go Forth and Find a Flu Vaccine

| Kjetil Ree

Bill Gates has issued a challenge to help researchers push for a universal flu vaccine.

Disease Area Drug discovery

Algal Boom

| Andrew Dahl

Algae are bacteria-fight experts. Why aren’t we using them more for drug discovery?

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register